Usability of Cognitive Improvement Software in Cognitively Impaired Patients: Pilot Study
NCT ID: NCT05634161
Last Updated: 2024-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
30 participants
OBSERVATIONAL
2022-11-21
2024-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of the Cognitive Enhancing ICT Contents in Patients With Mild Cognitive Impairment
NCT03405857
Effectiveness of a Home-Based Cognitive Rehabilitation Program in Patients With MCI
NCT05275153
Efficacy of the Cognitive Training Based on Location Information and Activity in People With Mild Cognitive Impairment
NCT03928613
NEUROFEEDBACK TRAINING FOR OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT: A PILOT STUDY
NCT04027725
Evaluation of the Effects of the New Program for Cognitive Enhancement and Improvement in the Elderly
NCT03401775
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive Improvement software
Usability assessment of cognitive improvement software
Cognitive improvement software
Cognitive improvement software
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive improvement software
Cognitive improvement software
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adequate vision, hearing and speaking for neuropsychological testing
* No difficulty in using mobile application using smartphone
* Patients with subjective memory complaints, confirmed by informants
* Cognitive impairment of SD 1 or greater from the age-adjusted normal range in Memory domain in CERAD-NP battery
* Global CDR 0.5 \~ 1
* Korean speaker
* Have an identified trial partner
* All subjects signed written consent
Exclusion Criteria
* History of transient ischemic attack, stroke, brain tumor
* History of diagnosis of major depression
* Symptoms that may interfere with the subject's testing procedure
* Cerebral hemorrhage
* Central nervous system infections
* Prohibited concomitant medication
* Known or suspected history of drug or alcohol abuse
55 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Boramae Hospital
OTHER
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jun Young Lee
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jun-Young Lee, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Psychiatry, Seoul National University College of Medicine, Department of Psychiatry, SMG-SNU Boramae Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul Metropolitan Government Seoul National University Boramae Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20-2022-48
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.